Evaluation of Evidence for Pathogenicity Demonstrates That BLK, KLF11, and PAX4 Should Not Be Included in Diagnostic Testing for MODY.

Laver, Thomas W; Wakeling, Matthew N; Knox, Olivia; Colclough, Kevin; Wright, Caroline F; Ellard, Sian; Hattersley, Andrew T; Weedon, Michael N; Patel, Kashyap A

Laver, Thomas W; Wakeling, Matthew N; Knox, Olivia; Colclough, Kevin; Wright, Caroline F; Ellard, Sian; Hattersley, Andrew T; Weedon, Michael N; Patel, Kashyap A.

Affiliation

Laver TW; Institute of Biomedical and Clinical Science, University of Exeter, Exeter, U.K.
Wakeling MN; Institute of Biomedical and Clinical Science, University of Exeter, Exeter, U.K.
Knox O; Institute of Biomedical and Clinical Science, University of Exeter, Exeter, U.K.
Colclough K; Exeter Genomics Laboratory, Royal Devon and Exeter NHS Foundation Trust, Exeter, U.K.
Wright CF; Institute of Biomedical and Clinical Science, University of Exeter, Exeter, U.K.
Ellard S; Institute of Biomedical and Clinical Science, University of Exeter, Exeter, U.K.
Hattersley AT; Institute of Biomedical and Clinical Science, University of Exeter, Exeter, U.K.
Weedon MN; Institute of Biomedical and Clinical Science, University of Exeter, Exeter, U.K.
Patel KA; Institute of Biomedical and Clinical Science, University of Exeter, Exeter, U.K.

Diabetes ; 71(5): 1128-1136, 2022 05 01.

Article in En | MEDLINE | ID: mdl-35108381

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 Type of study: Diagnostic_studies Limits: Humans Language: En Journal: Diabetes Year: 2022 Document type: Article Affiliation country: Reino Unido Country of publication: Estados Unidos

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google